| Copper deficiency anemia ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed Annals of hematology 97, 1527-1534, 2018 | 274 | 2018 |
| Protein S deficiency A Gupta, AM Tun, K Gupta, F Tuma | 36 | 2019 |
| Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials AM Tun, KZ Thein, WL Thein, E Guevara Future science OA 5 (9), FSO421, 2019 | 28 | 2019 |
| Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies AM Tun, SM Ansell Cancer Treatment Reviews 88, 102042, 2020 | 25 | 2020 |
| A rare concurrence of leiomyomatosis peritonealis disseminata, leiomyosarcoma of the pelvis and leiomyomatous nodule of the liver AM Tun, NM Tun, K Zin Thein, EE Naing, S Giashuddin, M Shulimovich Case Reports in Oncological Medicine 2016 (1), 3025432, 2016 | 21 | 2016 |
| High-dose methotrexate is not associated with reduction in CNS relapse in patients with aggressive B-cell lymphoma: an international retrospective study of 2300 high-risk patients KL Lewis, LH Jakobsen, D Villa, S Bobillo, KE Smedby, KJ Savage, ... Blood 138, 181, 2021 | 20 | 2021 |
| Pernicious anemia: fundamental and practical aspects in diagnosis AM Tun, KZ Thein, ZW Myint, TH Oo Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2017 | 17 | 2017 |
| Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma A Castellino, AM Tun, Y Wang, TM Habermann, RL King, KM Ristow, ... Blood Cancer Journal 11 (1), 1-8, 2021 | 16 | 2021 |
| Vitamin B12 deficiency-related pseudo-thrombotic microangiopathy might be misdiagnosed and treated with plasma product therapy: review of the literature and analysis of the … AM Tun, ZW Myint, CR Hernandez, E Guevara, KZ Thein, TH Oo Blood 130, 5576, 2017 | 16 | 2017 |
| Invasive aspergillosis in a patient with stage III (or 3a or 3b) non‐small‐cell lung cancer treated with durvalumab A Gupta, A Tun, K Ticona, A Baqui, E Guevara Case Reports in Oncological Medicine 2019 (1), 2178925, 2019 | 15 | 2019 |
| Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma AM Tun, S Maliske, Y Wang, DJ Inwards, TM Habermann, I Micallef, ... Transplantation and cellular therapy 28 (9), 610-617, 2022 | 13 | 2022 |
| High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma KL Lewis, LH Jakobsen, D Villa, KE Smedby, KJ Savage, TA Eyre, ... Journal of Clinical Oncology 41 (35), 5376-5387, 2023 | 10 | 2023 |
| A case of classic Kaposi sarcoma in an immunocompetent human immunodeficiency virus–negative Dominican man K Gupta, A Tun, A Gupta, LB Berkowitz, R Anwar, Y Liu, E Guevara SAGE Open Medical Case Reports 8, 2050313X20938249, 2020 | 9 | 2020 |
| Molecular genetics and the role of molecularly targeted agents in metastatic colorectal carcinoma A Naeem, AM Tun, E Guevara Journal of Gastrointestinal Cancer 51, 387-400, 2020 | 9 | 2020 |
| Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study AM Tun, A Khurana, R Mwangi, BK Link, Y Wang, AL Feldman, ... Blood advances 6 (17), 5210-5221, 2022 | 7 | 2022 |
| Updated meta-analysis of randomized controlled trials to evaluate the incidence of infection and pneumonia in patients with multiple myeloma treated with daratumumab TW Htut, AM Tun, A Sultan, MA Win, S Swarup, EM Phyu, PP Hlaing, ... Blood 134, 4771, 2019 | 6 | 2019 |
| Mogamulizumab-associated rash (MAR) correlates with longer progression free survival in cutaneous T cell lymphoma (CTCL) B Hu, S Atrash, L Cohen, SK Barta, Y Zhang, L Sokol, A Ayers, ... Blood 140 (Supplement 1), 1488-1490, 2022 | 5 | 2022 |
| Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Initial Results from the … IW Flinn, LE Budde, AM Tun, JM Burke, B Anz, S Peles, JP Sharman, ... Blood 142, 3029, 2023 | 4 | 2023 |
| Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy Y Wang, MC Larson, SR Hwang, A Kumar, A Joseph, BT Hill, TR Brooks, ... Blood 142, 300, 2023 | 3 | 2023 |
| Is chimeric antigen receptor T cell (CART) a destination procedure? Lower socioeconomic class who live farther from center have less access to CART. N Ahmed, E Shippey, C Kus, A Appenfeller, MS Hoffmann, AM Tun, ... Journal of Clinical Oncology 39 (15_suppl), e18562-e18562, 2021 | 3 | 2021 |
Kyaw Zin TheinComprehensive Cancer Centers of Nevada - Central Valley在 usoncology.com 的电子邮件经过验证
